Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt